DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant
Clinical trial NCT03208244 · TERMINATED
Trial details
- NCT number
- NCT03208244
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-09
- Primary completion
- 2021-04-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.